Kehua Biotech (KHB) Company Introduction

Kehua Biotech (KHB) Company Introduction

Shanghai Kehua Bio-Engineering Co., Ltd. (hereinafter referred to as KHB, Stock code: 002022.SZ) is an IVD company that boasts a full line of medical diagnostic products. Since its foundation in 1981, KHB has developed into a hi-tech company that integrates R&D, manufacturing and marketing business operation. In 2004, it was listed in the SME Board of Shenzhen Stock Exchange (SZSE).

Headquartered in Shanghai, KHB has set up R&D centers and production bases in a number of countries and regions including Italy, Shenzhen, Xi’an, and Suzhou and 33 subsidiaries. Currently, the company has nearly 2,000 employees, and its subsidiary Tianlong Technology has nearly 1000 employees.

Driven by the company’s R&D and innovation capability, KHB has built two R&D technology platforms for clinical IVD reagents and full automatic analyzers in order to progressively promote the serial development and integration of reagents and instruments. Focusing on immune diagnosis, biochemical diagnosis, molecular diagnosis and POCT (point-of-care testing)

#Biotech #Diagnostics #lmmunoassay #IVD #Reagent #Analyzer #Medical #Biochemical #ELISA #ColloidalGold #MolecularDiagnostics #POCT #ClinicalChemistry